Literature DB >> 12766983

Maximal voluntary ventilation in myasthenia gravis.

Ioannis Heliopoulos1, Georgios Patlakas, Kostantinos Vadikolias, Nicolaos Artemis, Kleopas A Kleopa, Eustratios Maltezos, Haritomeni Piperidou.   

Abstract

Assessment of respiratory muscle weakness is important at all stages of myasthenia gravis. The maximal voluntary ventilation (MVV) is an objective dynamic method for measuring the working capacity of respiratory muscles. The clinical value of this method was studied in 24 newly diagnosed patients with myasthenia gravis, classified according to Osserman criteria (grades I, IIa, and IIb). The MVV values were normal in group I, whereas a characteristic "myasthenic pattern" of decremental respiratory volumes was demonstrated during MVV in group IIa and IIb patients, with or without dyspnea. Despite some limitations and lack of specificity, MVV may be a valuable tool in the assessment of respiratory dysfunction in patients with myasthenia gravis. Muscle Nerve, 27: 715-719, 2003

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12766983     DOI: 10.1002/mus.10378

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  11 in total

1.  Causes of death among patients with myasthenia gravis in Norway between 1951 and 2001.

Authors:  J F Owe; A K Daltveit; N E Gilhus
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-02       Impact factor: 10.154

Review 2.  Update on respiratory management of critically ill neurologic patients.

Authors:  Alejandro A Rabinstein
Journal:  Curr Neurol Neurosci Rep       Date:  2005-11       Impact factor: 5.081

3.  Major motor-functional determinants associated with poor self-reported health-related quality of life in myasthenia gravis patients.

Authors:  David Cioncoloni; Stefania Casali; Federica Ginanneschi; Marisa Carone; Boni Veronica; Alessandro Rossi; Fabio Giannini
Journal:  Neurol Sci       Date:  2016-04-01       Impact factor: 3.307

4.  Long-term respiratory muscle endurance training in patients with myasthenia gravis: first results after four months of training.

Authors:  Beate Rassler; Grit Marx; Stephanie Hallebach; Petra Kalischewski; Irene Baumann
Journal:  Autoimmune Dis       Date:  2011-07-07

5.  Anaesthetic management of a patient with myasthenia gravis for abdominal surgery using sugammadex.

Authors:  Alina Rudzka-Nowak; Mariusz Piechota
Journal:  Arch Med Sci       Date:  2011-05-17       Impact factor: 3.318

Review 6.  Myasthenia gravis at the crossroad of COVID-19: focus on immunological and respiratory interplay.

Authors:  Giuliana Galassi; Alessandro Marchioni
Journal:  Acta Neurol Belg       Date:  2021-04-02       Impact factor: 2.396

7.  Lung function in post-poliomyelitis syndrome: a cross-sectional study.

Authors:  Claudio Andre Barbosa de Lira; Fábio Carderelli Minozzo; Bolivar Saldanha Sousa; Rodrigo Luiz Vancini; Marília dos Santos Andrade; Abrahão Augusto Juviniano Quadros; Acary Souza Bulle Oliveira; Antonio Carlos da Silva
Journal:  J Bras Pneumol       Date:  2013 Jun-Aug       Impact factor: 2.624

8.  General Anesthesia Using Supraglottic Airway Device in a Myasthenic Patient Undergoing Reverse Shoulder Arthroplasty.

Authors:  Shaila S Kamath; Julie C R Misquith
Journal:  Anesth Essays Res       Date:  2018 Apr-Jun

9.  Respiratory Muscle Training Improves Functional Outcomes and Reduces Fatigue in Patients with Myasthenia Gravis: A Single-Center Hospital-Based Prospective Study.

Authors:  Che-Wei Hsu; Hui-Chen Lin; Wan-Chen Tsai; Yun-Ru Lai; Chih-Cheng Huang; Yu-Jih Su; Ben-Chung Cheng; Mao-Chang Su; Wei-Che Lin; Chia-Ling Chang; Wen-Neng Chang; Meng-Chih Lin; Cheng-Hsien Lu; Nai-Wen Tsai
Journal:  Biomed Res Int       Date:  2020-03-19       Impact factor: 3.411

10.  Effect of Two Different Rehabilitation Approaches on Pulmonary Functional Tests, Neuromuscular Functions and Quality of Life in Juvenile Myasthenia Gravis: A Randomized Controlled Trial Study.

Authors:  Rasha A Mohamed; El Sayed H Mohamed; Mohamed A Basiouny; Ibrahim M Hamoda; El Sayed M Hanoura; Elbadawy I Elhenedi; Abd El Aziz A Sherief
Journal:  Medicina (Kaunas)       Date:  2022-03-02       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.